SquamousCellCarcinomaofSkin near Palm Harbor, FL

Biography: Dr. Sotomayor is the director of the newly established Cancer Institute at Tampa General Hospital. He is a pioneer in the field of cancer immunology and immunotherapy and an internationally renowned expert in lymphoma research and treatment. Prior to joining Tampa General, he was the director of the George Washington University Cancer Center with responsibility and authority over all aspects of cancer care and research at GW and affiliated health systems. He was also a professor of medicine in the division of hematology/oncology at George Washington University School of Medicine and Health Sciences. Fluent in English and Spanish, Dr. Sotomayor specializes in the treatment of lymphomas and leukemias. The accomplished physician-scientist's ongoing research is directed toward cancer immunology and immunotherapy with special focus in developing novel immune-based approaches for the treatment of lymphomas and other hematologic malignancies. Considered as a world expert in mantle cell lymphoma (MCL), he has more than 140 publications including seminal discoveries published in top tier journals such as Nature Immunology, Nature Medicine, Blood, Proceedings of the National Academy of Sciences, Cancer Cell among others. He has been the recipient of several awards, including the recipient of the National Cancer Institute (NCI) CURE Lifetime Achievement award in 2017. Dr. Sotomayor is involved in several major medical societies and organizations and currently is a member of the Scientific Advisory Board, Lymphoma Research Foundation, member of the Executive Committee of the Mantle Cell Lymphoma Consortium and member of several committees of the American Association for Cancer Research (AACR). He has also served in committees at the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO) and the National Cancer Institute (NCI)

Care Philosophy: Dr Costa is a Medical Oncologist at the Department of Breast Oncology at Moffitt Cancer Center in the Clinical Investigator Track since 2017. In 2011, Dr Costa completed a Master Degree in Clinical Research at University of Pittsburgh and Clinical Fellowship Training at Allegheny General Hospital, Pittsburgh, Pennsylvania. Dr Costa was an Instructor at the Developmental Therapeutics Program at Northwestern University, Chicago, where he developed early phase clinical trials for the treatment of breast cancer. He has already authored and co-authored over 40 scientific manuscripts.

Care Philosophy: Dr Jennifer Eatrides is a member of the Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. Dr Eatrides earned her MD degree with a research focus at the University of South Florida Morsani College of Medicine. She completed an Internal Medicine Residency and completed a Hematology and Oncology Fellowship at the University of South Florida and Moffitt Cancer Center. Dr Eatrides has a particular interest in hematologic malignancies. The MMG faculty at TGH provides invaluable medical oncology services to the large patient population of this leading regional hospital.

Care Philosophy: Dr Sharjeel Hooda is a Clinical Instructor-Member in the Moffitt Cancer Center Department of Satellite and Community Oncology. Dr Hooda is based at Moffitt International Plaza (MIP). Dr Hooda earned his MD and MS in Clinical Research at Emory University, Atlanta, Georgia. He completed an Internal Medicine Residency at Cleveland Clinic in Ohio where he also served as Chief Resident in Quality and Patient Safety. Dr Hooda completed a Hematology and Oncology Fellowship at the University of South Florida and Moffitt Cancer Center he also served as Chief Quality Fellow in Medicine.

Care Philosophy: Dr Arnold Etame is a Neurological Surgeon and Scientist specializing in Neuro-Oncology at Moffitt Cancer Center, and Associate Professor of Oncology at the University of South Florida, Morsani College of Medicine. Dr Etame has extensive expertise in the treatment of malignant gliomas notably glioblastoma (GBM) and he is part of a very small group of neurosurgeons with National Institute of Health (NIH) funding to develop impactful therapies for glioblastoma. He performs a substantial number of surgeries in eloquent and non-eloquent regions of the brain with image-guided stereotactic techniques entailing functional MRI and DTI tractography neuro-navigation.

Care Philosophy: Dr Jaglal completed his hematology/oncology fellowship at the University of South Florida and Moffitt Cancer Center. His research interests are in benign hematologic disorders: hemophilia, von Willebrand's disease, anemias, hemostasis and thrombosis disorders. Clinically, Dr Jaglal is a hematologist/oncologist and member of Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. The MMG faculty at TGH provides invaluable oncology services to the large patient population of this leading regional hospital.

Care Philosophy: Dr Lancet, a Senior Member and Professor at Moffitt Cancer Center and Chair of the Department of Malignant Hematology, is well known for his expertise in the care of patients with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), myeloproliferative neoplasms, and other related hematologic cancers. He has a special interest in the care of older adults with these diseases and also leads the Leukemia Program here at Moffitt, where he has built a large portfolio of clinical trials for patients with AML and MDS. Dr Lancet completed his residency training in Internal Medicine and Hematology-Oncology fellowship at the University of Rochester (New York), before relocating to Moffitt Cancer Center in 2004.

Care Philosophy: Dr Chavez is an Associate Member in the Lymphoma Section of the Department of Malignant Hematology at Moffitt Cancer Center. Dr Chavez earned his MD from the Medical School at the Universidad Peruana Cayetano Heredia in Lima, Peru. He completed his residency in Hematology at Hospital Edgardo Rebagliati Martins/Universidad Peruana Cayetano Heredia in Lima, Peru. He did his Internal Medicine training at the State University of New York in Buffalo, New York and completed his Medical Oncology training at the University of South Florida/Moffitt Cancer Center. Dr Chavez is board-certified in Internal Medicine and Medical Oncology.

Care Philosophy: Jhanelle E Gray, MD is the Department Chair, Program Leader and a Senior Member for Thoracic Oncology at the Moffitt Cancer Center (MCC), co-Leader of the Cancer Center Support Grant Molecular Medicine Program and Professor in the Department of Oncologic Sciences at the University of South Florida Morsani College of Medicine. A renowned Thoracic medical oncologist and clinical scientist, Dr Gray is actively involved and leads numerous clinical research trials that investigate novel immunotherapeutic and targeted therapy drug combinations for lung cancer which have greatly influenced standard of care treatment. Her research has generated over 80 publications in scholarly, peer-reviewed journals, including original manuscripts and reviews.

Care Philosophy: Dr Kenneth Shain is an associate member in the Malignant Hematology program in the Department of Malignant Hematology, Tumor Biology, and the Chemical Biology and Molecular Medicine Program. Dr Shain has also been appointed as an Assistant Professor at the University of South Florida Morsani College of Medicine in the Department of Oncologic Sciences.Dr Shain is also a Director of the Myeloma Research Center.Dr Shain is a clinician scientist with time divided by clinic, clinic trials and translational research with a primary focus in multiple myeloma and other plasma cell relation disorders (including Waldenstrom Macroglobulinemia and Primary Amyloidosis).

Care Philosophy: Dr Chadha is an Assistant Professor at the University of South Florida, Morsani College of Medicine. After graduating from New York University, he completed his medical degree from the New York Institute of Technology College of Osteopathic Medicine and completed an Internal Medicine Residency at Icahn School of Medicine at Mount Sinai. Most recently, he completed a Hematology/Oncology Fellowship at the Donald and Barbara Zucker School of Medicine at Hofstra Northwell Health Lenox Hill Hospital. Dr Chadha's focus is solid tumor oncology, with clinical interests in genitourinary tract tumors, including prostate cancer, bladder cancer, kidney cancer, testicular cancer, and thoracic malignancies.